| 1 |
34384758 | RORγ is a context-specific master regulator of cholesterol biosynthesis and an emerging therapeutic target in cancer and autoimmune diseases. | 2022 Feb |
1 |
| 2 |
34840111 | Mechanistic roles of mutant p53 governing lipid metabolism. | 2022 Jan |
1 |
| 3 |
35391801 | Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions. | 2022 |
2 |
| 4 |
35398929 | P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis. | 2022 Apr 10 |
1 |
| 5 |
35532255 | Exploring the Mechanism of Yi-Jing Decoction in Treating Polycystic Ovary Syndrome by Using Network Pharmacology. | 2022 May 8 |
1 |
| 6 |
34069902 | Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma. | 2021 May 18 |
3 |
| 7 |
34346836 | Identification of four gastric cancer subtypes based on genetic analysis of cholesterogenic and glycolytic pathways. | 2021 Dec |
1 |
| 8 |
34572923 | Prostate Cancer-Focus on Cholesterol. | 2021 Sep 19 |
1 |
| 9 |
30833076 | Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer. | 2019 Apr 16 |
2 |
| 10 |
30863051 | A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer. | 2019 |
1 |
| 11 |
28118603 | Disabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastoma. | 2017 Feb 28 |
1 |
| 12 |
28710022 | Taxifolin reduces the cholesterol oxidation product-induced neuronal apoptosis by suppressing the Akt and NF-κB activation-mediated cell death. | 2017 Sep |
1 |
| 13 |
27288732 | Lysosomotropic cationic drugs induce cytostatic and cytotoxic effects: Role of liposolubility and autophagic flux and antagonism by cholesterol ablation. | 2016 Aug 15 |
1 |
| 14 |
27374783 | PGMA-based gene carriers with lipid molecules. | 2016 Aug 19 |
1 |
| 15 |
27382207 | Differential Expressions of p53, p53R2, hRRM2 and PBR in Chronic Lymphocytic Leukemia: A Correlation with Intracellular Cholesterol. | 2016 Jul |
1 |
| 16 |
27419353 | The Hippo pathway, p53 and cholesterol. | 2016 Sep |
1 |
| 17 |
27703600 | Cholesterol Retards Senescence in Bone Marrow Mesenchymal Stem Cells by Modulating Autophagy and ROS/p53/p21Cip1/Waf1 Pathway. | 2016 |
1 |
| 18 |
27775703 | DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway. | 2016 Nov |
1 |
| 19 |
26350565 | The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells. | 2015 Dec |
1 |
| 20 |
24211075 | A cationic cholesterol based nanocarrier for the delivery of p53-EGFP-C3 plasmid to cancer cells. | 2014 Jan |
1 |
| 21 |
21802012 | Cholesterol secosterol aldehydes induce amyloidogenesis and dysfunction of wild-type tumor protein p53. | 2011 Jul 29 |
2 |
| 22 |
20466611 | Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a downstream prostate cell growth-suppressor gene. | 2010 Aug |
1 |
| 23 |
19059205 | Characterizing components of the Saw Palmetto Berry Extract (SPBE) on prostate cancer cell growth and traction. | 2009 Feb 13 |
1 |
| 24 |
17234782 | Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells. | 2007 Jan 15 |
1 |
| 25 |
11273776 | Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. | 2001 Mar |
1 |
| 26 |
10684646 | p53 regulates caveolin gene transcription, cell cholesterol, and growth by a novel mechanism. | 2000 Feb 29 |
1 |